Journal Home
Access this journal onSciVerse ScienceDirect
Visit SciVerse ScienceDirect to see if you have access via your institution.
Search for
Advanced Search - MEDLINE - My Recent Searches - My Saved Searches - Search Tips
More periodicals:

Volume 5, Issue 1, Page 10 (January 2010)


View previous. 12 of 43 View next.

PREVIEW

FULL TEXT

FULL-TEXT PDF (83 KB)

CITATION ALERT

CITED BY

EXPORT CITATION

EMAIL TO A COLLEAGUE

RIGHTS/PERMISSIONS

DOWNLOAD IMAGES

NEED REPRINTS?

Denosumab Bests Zoledronic Acid for Bone Metastases

BRUCE JANCIN

SAN ANTONIO — Denosumab proved superior to zoledronic acid in delaying or preventing complications from bone metastases in breast cancer patients in a large phase III clinical trial.

PII: S1558-0164(10)70012-2

doi:10.1016/S1558-0164(10)70012-2


View previous. 12 of 43 View next.

Copyright © 2012 Elsevier Inc. All rights reserved. | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us |
The content on this site is intended for health professionals.